United States · FDA National Drug Code directory
Zinc Therapy
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71819-007_29baa37a-11fd-d45b-e063-6294a90a12c4
- Product NDC
- 71819-007
- Form
- LIQUID
- Composition / generic term
- Pyrithione Zinc
- Labeler
- D3 Development, Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20180123
- Source listing expiry
- 20261231
Source-listed ingredients
- PYRITHIONE ZINC — 2 g/100mL
These values do not establish equivalence or a dose recommendation.
Packages
- 118 mL in 1 BOTTLE, PLASTIC (71819-007-04) · 71819-007-04
- 296 mL in 1 BOTTLE, PLASTIC (71819-007-10) · 71819-007-10
- 355 mL in 1 BOTTLE, PLASTIC (71819-007-12) · 71819-007-12
- 1893 mL in 1 BOTTLE, PLASTIC (71819-007-64) · 71819-007-64
- 3785 mL in 1 BOTTLE, PLASTIC (71819-007-99) · 71819-007-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →